中国艾滋病流行病学研究新进展

何纳

doi:10.16462/j.cnki.zhjbkz.2021.12.001

中国艾滋病流行病学研究新进展

doi: 10.16462/j.cnki.zhjbkz.2021.12.001

何纳^,

200032 上海，复旦大学公共卫生学院流行病学教研室

基金项目:

上海市公共卫生重点学科建设项目 GWV-10.1-XK16

详细信息

通讯作者:
何纳，E-mail: nhe@shmu.edu.cn

中图分类号: R512.91
计量
- 文章访问数: 7610
- HTML全文浏览量: 1884
- PDF下载量: 1648
- 被引次数: 0
出版历程
- 收稿日期: 2021-11-11
- 修回日期: 2021-11-18
- 网络出版日期: 2021-12-27
- 刊出日期: 2021-12-10

New progress of AIDS epidemiology in China

HE Na^,

Department of Epidemiology, School of Public Health, Fudan University, Shanghai 200032, China

Funds:

Shanghai Municipal Key Disciplinary Project of Public Health GWV-10.1-XK16

More Information

Corresponding author: HE Na, E-mail: nhe@shmu.edu.cn

摘要

摘要: 2021年是艾滋病发现40周年，我国艾滋病流行呈现新特征，艾滋病防控工作也由“2020年底实现90-90-90的目标”转入到“2025年底实现95-95-95-95的目标”的新阶段。本文简要概述了我国艾滋病流行病学研究的最新进展，以期探讨实现“十四五”艾滋病防治目标和“2030年终结艾滋病”愿景的科学路径。
- 艾滋病 /
- 流行病学 /
- 防控 /
- 新特征 /
- 新进展
Abstract: At the 40^th anniversary of the first global AIDS report, China's HIV/AIDS epidemic presents with new characteristics, and the national goal of anti-HIV/AIDS has also shifted from "the 90-90-90 goal by 2020" to "the 95-95-95-95 goal by 2025". This review briefly summarizes the most recent advances in the epidemiological research of HIV/AIDS in China, aiming to provide insights on the scientific pathways to achieving the national goal of HIV/AIDS prevention and control for the "Fourteenth Five-Years Plan" as well as the hope for "Ending AIDS by 2030".
- HIV/AIDS /
- Epidemiology /
- Prevention and control /
- New characteristics /
- New Advances

HTML全文

参考文献(32)

[1]	Dong MJ, Peng B, Liu ZF, et al. The prevalence of HIV among MSM in China: a large-scale systematic analysis[J]. BMC Infect Dis, 2019, 19(1): 1-20. DOI: 10.1186/s12879-019-4559-1.
[2]	李玲玲, 江震, 宋炜路, 等. 应用德尔菲法构建男男性行为者个体HIV感染风险评估工具[J]. 中华流行病学杂志, 2017, 38(10): 1426-1430. DOI: 10.3760/cma.j.issn.0254-6450.2017.10.026. Li LL, Jiang Z, Song WL, et al. Development of HIV infection risk assessment tool for men who have sex with men based on Delphi method[J]. Chin J Epidemiol, 2017, 38(10): 1426-1430. DOI: 10.3760/cma.j.issn.0254-6450.2017.10.026.
[3]	Yun K, Chu Z, Zhang J, et al. Mobile phone intervention based on an HIV risk prediction tool for HIV prevention among men who have sex with men in China: randomized controlled trial[J]. JMIR Mhealth Uhealth, 2021, 9(4): e19511. DOI: 10.2196/19511.
[4]	Hu QH, Qian HZ, Li JM, et al. Assisted partner notification and uptake of HIV testing among men who have sex with men: a randomized controlled trial in China[J]. Lancet Reg Health West Pac, 2021, 12: 100171. DOI: 10.1016/j.lanwpc.2021.100171.
[5]	Tang W, Wei C, Cao B, et al. Crowdsourcing to expand HIV testing among men who have sex with men in China: a closed cohort stepped wedge cluster randomized controlled trial[J]. PLoS Med, 2018, 15(8): e1002645. DOI: 10.1371/journal.pmed.1002645.
[6]	Wu D, Zhou Y, Yang N, et al. Social media-based secondary distribution of human immunodeficiency virus/syphilis self-testing among Chinese men who have sex with men[J]. Clin Infect Dis, 2021, 73(7): e2251-e2257. DOI: 10.1093/cid/ciaa825.
[7]	徐俊杰, 黄晓婕, 刘昕超, 等. 中国HIV暴露前预防用药专家共识[J]. 中国艾滋病性病, 2020, 26(11): 1265-1271. doi: 10.13419/j.cnki.aids.2020.11.34 Xu JJ, Huang XJ, Liu XC, et al. Chinese experts' consensus on the use of HIV pre-exposure prophylaxis[J]. Chin J AIDS STD, 2020, 26(11): 1265-1271. DOI: 10.13419/j.cnki.aids.2020.11.34.
[8]	Fu Y, Ashuro AA, Feng X, et al. Willingness to use HIV pre-exposure prophylaxis and associated factors among men who have sex with men in Liuzhou, China[J]. AIDS Res Ther, 2021, 18(1): 46. DOI: 10.1186/s12981-021-00374-8.
[9]	Cui Z, Huang H, Zhang T, et al. Low awareness of and willingness to use PrEP in the Chinese YMSM: an alert in YMSM HIV prevention[J]. HIV Med, 2021, 22(3): 185-193. DOI: 10.1111/hiv.12990.
[10]	王春萍, 郭琴, 韩卓洳, 等. 中国老年人群艾滋病防治核心知识知晓率的Meta分析[J]. 中国艾滋病性病, 2019, 25(2): 148-152. DOI: 10.13419/j.cnki.aids.2019.02.10. Wang CP, Guo Q, Han ZR, et al. Awareness rate of HIV/AIDS core knowledge among the elderly: a meta-analysis[J]. Chin J AIDS STD, 2019, (2): 148-152. DOI: 10.13419/j.cnki.aids.2019.02.10.
[11]	张晗希, 韩孟杰, 周郁, 等. 我国50岁及以上人群HIV感染率的Meta分析[J]. 中华流行病学杂志, 2020, 41(1): 96-102. DOI: 10.3760/cma.j.issn.0254-6450.2020.01.018. Zhang HX, Han MJ, Zhou Y, et al. HIV infection rate in people aged 50 years and older in China: a Meta-analysis[J]. Chin J Epidemiol, 2020, 41(1): 96-102. DOI: 10.3760/cma.j.issn.0254-6450.2020.01.018.
[12]	蔡畅, 汤后林, 陈方方, 等. 我国2010―2019年新报告青年学生HIV/AIDS基本特征及趋势分析[J]. 中华流行病学杂志, 2020, 41(9): 1455-1459. DOI: 10.3760/cma.j.cn112338-20200417-00592. Cai C, Tang HL, Chen FF, et al. Characteristics and trends of newly reported HIV infection in young students in China, 2010-2019[J]. Chin J Epidemiol, 2020, 41(9): 1455-1459. DOI: 10.3760/cma.j.cn112338-20200417-00592.
[13]	Lyu Y, Li G, Hu M, et al. Anonymous linkage between college students and human immunodeficiency virus (HIV) facilities: systematic evaluation of urine self-collection for HIV testing initiative in China[J]. Clin Infect Dis, 2021, 73(5): e1108-e1115. DOI: 10.1093/cid/ciaa1816.
[14]	Zhang H, Hsieh E, Wang L, et al. HIV/AIDS among female sex workers in China: epidemiology and recent prevention strategies[J]. Curr HIV/AIDS Rep, 2020, 17(2): 151-160. DOI: 10.1007/s11904-019-00477-y.
[15]	Zhang C, Koniak-Griffin D, Qian HZ, et al. Impact of providing free HIV self-testing kits on frequency of testing among men who have sex with men and their sexual partners in China: a randomized controlled trial[J]. PLoS Med, 2020, 17(10): e1003365. DOI: 10.1371/journal.pmed.1003365.
[16]	Liu XJ, McGoogan JM, Wu ZY. Human immunodeficiency virus/acquired immunodeficiency syndrome prevalence, incidence, and mortality in China, 1990 to 2017: a secondary analysis of the Global Burden of Disease Study 2017 data[J]. Chin Med J, 2021, 134(10): 1175-1180. DOI: 10.1097/cm9.0000000000001447.
[17]	Liu J, Hou Y, Sun L, et al. High population-attributable fractions of traditional risk factors for non-AIDS-defining diseases among people living with HIV in China: a cohort study[J]. Emerg Microbes Infect, 2021, 10(1): 416-423. DOI: 10.1080/22221751.2021.1894904.
[18]	Liu D, Shen Y, Zhang R, et al. Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China[J]. J Gastroenterol Hepatol, 2021, 36(6): 1670-1678. DOI: 10.1111/jgh.15320.
[19]	徐小慧, 陈潇潇, 林海江, 等. 台州市HIV感染者高血压治疗率与控制率现状[J]. 中华疾病控制杂志, 2020, 24(7): 785-790. DOI: 10.16462/j.cnki.zhjbkz.2020.07.008. Xu XH, Chen XX, Lin HJ, et al. Hypertension treatment and control rates among HIV-infected individuals in Taizhou City[J]. Chin J Dis Control Prev, 2020, 24(7): 785-790. DOI: 10.16462/j.cnki.zhjbkz.2020.07.008.
[20]	袁诗颖, 陈潇潇, 林海江, 等. HIV感染者神经认知功能及可调控危险因素的现况研究[J]. 中华疾病控制杂志, 2020, 24(12): 1365-1370. DOI: 10.16462/j.cnki.zhjbkz.2020.12.001. Yuan SY, Chen XX, Lin HJ, et al. Prevalence study of neurocognitive functions and modifiable risk factors in HIV-infected individuals[J]. Chin J Dis Control Prev, 2020, 24(12): 1365-1370. DOI: 10.16462/j.cnki.zhjbkz.2020.12.001.
[21]	Wang X, Zhang Y, Liu Y, et al. Phylogenetic analysis of sequences in the HIV database revealed multiple potential circulating recombinant forms in China[J]. AIDS Res Hum Retroviruses, 2021, 37(9): 694-705. DOI: 10.1089/aid.2020.0190.
[22]	Ma N, Chen XH, Zhao Y, et al. HIV-1 molecular transmission network among sexually transmitted populations in Liaoning Province, China[J]. Medicine (Baltimore), 2021, 100(28): e26640. DOI: 10.1097/md.0000000000026640.
[23]	Yin YQ, Zhou Y, Lu J, et al. Molecular epidemiology of HIV-1 in Jiangsu Province, southeast China: genotypes and HIV-1 transmission networks among newly diagnosed men having sex with men in 2017[J]. AIDS Res Hum Retroviruses, 2021, 37(1): 62-69. DOI: 10.1089/AID.2020.0165.
[24]	Li K, Liu M, Chen H, et al. Using molecular transmission networks to understand the epidemic characteristics of HIV-1 CRF08_BC across China[J]. Emerg Microbes Infect, 2021, 10(1): 497-506. DOI: 10.1080/22221751.2021.1899056.
[25]	Zuo L, Liu K, Liu H, et al. Trend of HIV-1 drug resistance in China: a systematic review and meta-analysis of data accumulated over 17 years (2001-2017)[J]. E Clinical Medicine, 2020, 18: 100238. DOI: 10.1016/j.eclinm.2019.100238.
[26]	Zhao D, Ding Y, Lin H, et al. Mitochondrial haplogroups N9 and G are associated with metabolic syndrome among human immunodeficiency virus-infected patients in China[J]. AIDS Res Hum Retroviruses, 2019, 35(6): 536-543. DOI: 10.1089/aid.2018.0151.
[27]	Ding Y, Lin H, Chen X, et al. Comprehensive metabolomics profiling reveals common metabolic alterations underlying the four major non-communicable diseases in treated HIV infection[J]. EBioMedicine, 2021, 71: 103548. DOI: 10.1016/j.ebiom.2021.103548.
[28]	Dong RH, Lin HJ, Chen XX, et al. Gut microbiota and fecal metabolites associated with neurocognitive impairment in HIV-infected population[J]. Front Cell Infect Microbiol, 2021, 11: 723840. DOI: 10.3389/fcimb.2021.723840.
[29]	Huang J, Xie NH, Hu XJ, et al. Epidemiological, virological and serological features of coronavirus disease 2019 (COVID-19) cases in people living with human immunodeficiency virus in Wuhan: a population-based cohort study[J]. Clin Infect Dis, 2021, 73(7): e2086-e2094. DOI: 10.1093/cid/ciaa1186.
[30]	Shi LG, Tang WM, Hu HY, et al. The impact of COVID-19 pandemic on HIV care continuum in Jiangsu, China[J]. BMC Infect Dis, 2021, 21(1): 1-9. DOI: 10.1186/s12879-021-06490-0.
[31]	Jiang H, Xie Y, Xiong Y, et al. HIV self-testing partially filled the HIV testing gap among men who have sex with men in China during the COVID-19 pandemic: results from an online survey[J]. J Int AIDS Soc, 2021, 24(5): e25737. DOI: 10.1002/jia2.25737.
[32]	Huang XJ, Yu MH, Fu GF, et al. Willingness to receive COVID-19 vaccination among people living with HIV and AIDS in China: nationwide cross-sectional online survey[J]. JMIR Public Health Surveill, 2021, 7(10): e31125. DOI: 10.2196/31125.